Oligoclonal T cells transiently expand and express TIM3 and LAG3 following CD19 CAR t cell therapy.

被引：0

作者：

Petersen, Christopher Thomas

Jagirdar, Neera

Waller, Edmund K.

机构：

[1] Emory Univ, Atlanta, GA USA

[2] Emory Clin, Atlanta, GA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.e19017

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e19017

引用

页数：6

共 50 条

[21] Blocking TIM3:Galectin-9 pathway enhances in vivo CAR19T cell function [J].

Falgas, A. ;

Zanetti, S. R. ;

Martinez-Moreno, A. ;

Panisello, C. ;

Romecin, P. A. ;

Diez Alonso, L. ;

Alvarez Vallina, L. ;

Bueno, C. ;

Menendez, P. .

KLINISCHE PADIATRIE, 2023, 235 (03) :194-194

[22] Oligoclonal expansion and loss of cytotoxic functionality of CAR-T cells in a DLBCL patient after CD19.CAR-T cell therapy [J].

Mueller, F. ;

Schwingen, N. R. ;

Eisenhauer, N. ;

Aigner, M. ;

Schletter, M. ;

Lutzny-Geier, G. ;

Lischer, C. ;

Guese, E. ;

Gebhard, C. ;

Rehli, M. ;

Gonzalez, Vera J. ;

Eckstein, M. ;

Wiesmueller, M. ;

Erber, R. ;

Bruns, H. ;

Mackensen, A. ;

Voelkl, S. .

ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 :73-74

[23] Early and late hematologic toxicity following CD19 CAR-T cells [J].

Fried, Shalev ;

Avigdor, Abraham ;

Bielorai, Bella ;

Meir, Amilia ;

Besser, Michal J. ;

Schachter, Jacob ;

Shimoni, Avichai ;

Nagler, Arnon ;

Toren, Amos ;

Jacoby, Elad .

BONE MARROW TRANSPLANTATION, 2019, 54 (10) :1643-1650

[24] Early and late hematologic toxicity following CD19 CAR-T cells [J].

Shalev Fried ;

Abraham Avigdor ;

Bella Bielorai ;

Amilia Meir ;

Michal J. Besser ;

Jacob Schachter ;

Avichai Shimoni ;

Arnon Nagler ;

Amos Toren ;

Elad Jacoby .

Bone Marrow Transplantation, 2019, 54 :1643-1650

[25] Getting CD19 Into Shape: Expression of Natively Folded "Difficult-to- Express" CD19 for Staining and Stimulation of CAR-T Cells [J].

Lobner, Elisabeth ;

Wachernig, Anna ;

Gudipati, Venugopal ;

Mayrhofer, Patrick ;

Salzer, Benjamin ;

Lehner, Manfred ;

Huppa, Johannes B. ;

Kunert, Renate .

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8

[26] Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy [J].

Chou, Cassie K. ;

Turtle, Cameron J. .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (06) :653-664

[27] Oligoclonal T-cell expansion in a patient with bone marrow failure after CD19 CAR-T therapy for Richter-transformed DLBCL [J].

Rejeski, Kai ;

Wu, Zhijie ;

Blumenberg, Viktoria ;

Kunz, Wolfgang G. ;

Mueller, Susanna ;

Kajigaya, Sachiko ;

Gao, Shouguo ;

Buecklein, Veit L. ;

Froelich, Lisa ;

Schmidt, Christian ;

von Bergwelt-Baildon, Michael ;

Feng, Xingmin ;

Young, Neal S. ;

Subklewe, Marion .

BLOOD, 2022, 140 (20) :2175-2179

[28] Advancing CD19 CAR T Cell Therapy for Treatment of Primary Biliary Cholangitis [J].

Umeshappa, Channakeshava Sokke ;

Kolla, Harish Babu ;

Nanjundappa, Roopa Hebbandi .

JOURNAL OF IMMUNOLOGY, 2024, 212 (01)

[29] Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma [J].

Kuipers, Maria T. ;

Spanjaart, Anne M. ;

Bonifazi, Francesca ;

diBlasi, Roberta ;

Zinzani, Pier L. ;

Thieblemont, Catherine ;

Baudet, Mathilde ;

Biemond, Bart J. ;

Kok, Wouter E. M. ;

Kersten, Marie J. .

LEUKEMIA & LYMPHOMA, 2024, 65 (03) :399-402

[30] CD19 CAR-T Cell Therapy: High Efficacy in Autoimmune Diseases [J].

Brudermanns, Britta .

TRANSFUSIONSMEDIZIN, 2024, 14 (03) :126-126

← 1 2 3 4 5 →